The additive effects of obesity on myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance first-pass perfusion study.

Abstract

BACKGROUND:

The microvascular effects of obesity should be considered in diabetic individuals for elucidating underlying mechanisms and developing targeted therapies. This study aims to determine the effect of obesity on myocardial microvascular function in type 2 diabetes mellitus (T2DM) patients using cardiac magnetic resonance (CMR) first-pass perfusion imaging and assessed significant risk factors for microvascular dysfunction.

MATERIALS AND METHODS:

Between September 2016 and May 2018, 120 patients with T2DM (45.8% women [55 of 120]; mean age, 56.45 ± 11.97 years) and 79 controls (44.3% women [35 of 79]; mean age, 54.50 ± 7.79 years) with different body mass index (BMI) scales were prospectively enrolled and underwent CMR examination. CMR-derived perfusion parameters, including upslope, time to maximum signal intensity (TTM), maximum signal intensity (MaxSI), MaxSI (-baseline), and SI (baseline), and T2DM related risk factors were analyzed among groups/subgroups both in T2DM patients and controls. Univariable and multivariable linear and logistic regression analyses were performed to assess the potential additive effect of obesity on microvascular dysfunction in diabetic individuals.

RESULTS:

Compared with controls with comparable BMIs, patients with T2DM showed reduced upslope and MaxSI and increased TTM. For both T2DM and control subgroups, perfusion function gradually declined with increasing BMI, which was confirmed by all perfusion parameters, except for TTM (all P < 0.01). In multivariable linear regression analysis, BMI (β = - 0.516; 95% confidence interval [CI], - 0.632 to - 0.357; P < 0.001), female sex (β = 0.372; 95% CI, 0.215 to 0.475; P < 0.001), diabetes duration (β = - 0.169; 95% CI, - 0.319 to - 0.025; P = 0.022) and glycated haemoglobin (β = - 0.184; 95% CI, - 0.281 to - 0.039; P = 0.010) were significantly associated with global upslope in the T2DM group. Multivariable logistic regression analysis indicated that T2DM was an independent predictor of microvascular dysfunction in normal-weight (odds ratio[OR], 6.46; 95% CI, 2.08 to 20.10; P = 0.001), overweight (OR, 7.19; 95% CI, 1.67 to 31.07; P = 0.008) and obese participants (OR, 11.21; 95% CI, 2.38 to 52.75; P = 0.002).

CONCLUSIONS:

Myocardial microvascular function gradually declined with increasing BMI in both diabetes and non-diabetes status. T2DM was associated with an increased risk of microvascular dysfunction, and obesity exacerbated the adverse effect of T2DM.

• Authors: Li Jiang, Ke Shi, Ying-Kun Guo, Yan Ren, Zhen-Lin Li, Chun-Chao Xia, Lei Li, Xi Liu, Lin-Jun Xie, Yue Gao, Meng-Ting Shen, Ming-Yan Deng, Zhi-Gang Yang
• Journal: Cardiovascular diabetology (Cardiovasc Diabetol) Vol. 19 Issue 1 Pg. 52 (05 06 2020) ISSN: 1475-2840 [Electronic] England
• PMID: 32375795 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Topics

• Aged
• Case-Control Studies
• Coronary Circulation
• Diabetes Mellitus, Type 2 (complications, diagnosis)
• Diabetic Cardiomyopathies (diagnostic imaging, etiology, physiopathology)
• Female
• Humans
• Magnetic Resonance Imaging, Cine
• Male
• Microcirculation
• Middle Aged
• Myocardial Perfusion Imaging (methods)
• Obesity (complications, diagnosis)
• Predictive Value of Tests
• Prospective Studies
• Risk Assessment
• Risk Factors